| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.67e-04 | 188 | 65 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 4.52e-04 | 46 | 65 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | retromer complex binding | 4.62e-04 | 10 | 65 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 6.74e-04 | 12 | 65 | 2 | GO:0048407 | |
| GeneOntologyCellularComponent | collagen type I trimer | 1.01e-05 | 2 | 67 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 4.02e-05 | 21 | 67 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | U2 snRNP | 9.73e-05 | 28 | 67 | 3 | GO:0005686 | |
| GeneOntologyCellularComponent | U12-type spliceosomal complex | 1.20e-04 | 30 | 67 | 3 | GO:0005689 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 5.87e-04 | 51 | 67 | 3 | GO:0071005 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 6.54e-04 | 12 | 67 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 6.54e-04 | 12 | 67 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 6.94e-04 | 54 | 67 | 3 | GO:0071011 | |
| GeneOntologyCellularComponent | WASH complex | 1.03e-03 | 15 | 67 | 2 | GO:0071203 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.17e-03 | 658 | 67 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | Schmidt-Lanterman incisure | 1.33e-03 | 17 | 67 | 2 | GO:0043220 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.51e-03 | 530 | 67 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | compact myelin | 2.04e-03 | 21 | 67 | 2 | GO:0043218 | |
| HumanPheno | Biconcave flattened vertebrae | 3.35e-05 | 2 | 30 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 3.35e-05 | 2 | 30 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 3.35e-05 | 2 | 30 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 3.35e-05 | 2 | 30 | 2 | HP:0005005 | |
| HumanPheno | Recurrent joint dislocation | 6.42e-05 | 14 | 30 | 3 | HP:0031869 | |
| HumanPheno | Popcorn calcification | 1.00e-04 | 3 | 30 | 2 | HP:6000871 | |
| HumanPheno | Dilatation of the ascending aorta | 1.11e-04 | 84 | 30 | 5 | HP:0005111 | |
| HumanPheno | Abnormality of subcutaneous fat tissue | 1.25e-04 | 86 | 30 | 5 | HP:0001001 | |
| HumanPheno | Femoral hernia | 1.96e-04 | 20 | 30 | 3 | HP:0100541 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 2.00e-04 | 4 | 30 | 2 | HP:0003023 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | COL4A2 TTBK2 ZSWIM8 ANKS6 WASHC2C HDAC4 KLF1 ACAN ZNF516 LMNB2 WASHC2A PCK1 EDN3 RYR1 FERMT3 COL1A1 COL1A2 | 1.29e-06 | 1269 | 51 | 17 | MP:0011111 |
| MousePheno | abnormal thoracic cage shape | 8.77e-05 | 24 | 51 | 3 | MP:0010099 | |
| MousePheno | respiratory distress | 9.35e-05 | 204 | 51 | 6 | MP:0001954 | |
| MousePheno | abnormal compact bone lamellar structure | 1.30e-04 | 5 | 51 | 2 | MP:0010970 | |
| MousePheno | decreased tendon stiffness | 1.30e-04 | 5 | 51 | 2 | MP:0003098 | |
| MousePheno | abnormal tendon stiffness | 1.94e-04 | 6 | 51 | 2 | MP:0003097 | |
| MousePheno | abnormal tendon physiology | 1.94e-04 | 6 | 51 | 2 | MP:0030802 | |
| Domain | FAM21 | 1.19e-05 | 2 | 65 | 2 | IPR027308 | |
| Domain | FAM21/CAPZIP | 3.57e-05 | 3 | 65 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 3.57e-05 | 3 | 65 | 2 | PF15255 | |
| Domain | Fib_collagen_C | 6.43e-04 | 11 | 65 | 2 | IPR000885 | |
| Domain | COLFI | 6.43e-04 | 11 | 65 | 2 | PF01410 | |
| Domain | NC1_FIB | 6.43e-04 | 11 | 65 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 6.43e-04 | 11 | 65 | 2 | PD002078 | |
| Domain | COLFI | 6.43e-04 | 11 | 65 | 2 | SM00038 | |
| Domain | TSP_1 | 1.38e-03 | 63 | 65 | 3 | PF00090 | |
| Domain | TSP1 | 1.51e-03 | 65 | 65 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.51e-03 | 65 | 65 | 3 | IPR000884 | |
| Domain | TSP1 | 1.51e-03 | 65 | 65 | 3 | PS50092 | |
| Domain | ADAM_spacer1 | 2.88e-03 | 23 | 65 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.88e-03 | 23 | 65 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.13e-03 | 24 | 65 | 2 | IPR013273 | |
| Domain | Collagen | 3.24e-03 | 85 | 65 | 3 | IPR008160 | |
| Domain | Collagen | 3.24e-03 | 85 | 65 | 3 | PF01391 | |
| Domain | Cadherin_cytoplasmic-dom | 3.40e-03 | 25 | 65 | 2 | IPR000233 | |
| Domain | Cadherin_C | 3.40e-03 | 25 | 65 | 2 | PF01049 | |
| Domain | Catenin_binding_dom | 4.56e-03 | 29 | 65 | 2 | IPR027397 | |
| Domain | - | 4.56e-03 | 29 | 65 | 2 | 4.10.900.10 | |
| Domain | VWC | 7.73e-03 | 38 | 65 | 2 | SM00214 | |
| Domain | VWFC_2 | 7.73e-03 | 38 | 65 | 2 | PS50184 | |
| Domain | Peptidase_M12B_N | 8.13e-03 | 39 | 65 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 8.13e-03 | 39 | 65 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 8.54e-03 | 40 | 65 | 2 | PS00427 | |
| Domain | Reprolysin | 8.54e-03 | 40 | 65 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 8.54e-03 | 40 | 65 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 8.54e-03 | 40 | 65 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 8.54e-03 | 40 | 65 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 8.96e-03 | 41 | 65 | 2 | IPR001762 | |
| Domain | VWF_dom | 9.39e-03 | 42 | 65 | 2 | IPR001007 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.62e-06 | 140 | 47 | 6 | M587 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.54e-05 | 15 | 47 | 3 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.74e-05 | 18 | 47 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.74e-05 | 18 | 47 | 3 | MM14882 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.24e-05 | 19 | 47 | 3 | M27221 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.70e-05 | 114 | 47 | 5 | MM14571 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.07e-04 | 28 | 47 | 3 | MM15957 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 1.07e-04 | 28 | 47 | 3 | M42541 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.17e-04 | 76 | 47 | 4 | M27219 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.46e-04 | 31 | 47 | 3 | M27805 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.61e-04 | 32 | 47 | 3 | MM14924 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.80e-04 | 85 | 47 | 4 | M16441 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 2.26e-04 | 7 | 47 | 2 | M48265 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 3.01e-04 | 8 | 47 | 2 | M48236 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.39e-04 | 41 | 47 | 3 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.18e-04 | 44 | 47 | 3 | M27812 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.55e-04 | 300 | 47 | 6 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.08e-04 | 47 | 47 | 3 | MM14925 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 5.41e-04 | 48 | 47 | 3 | MM15410 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 5.87e-04 | 11 | 47 | 2 | M9990 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 6.10e-04 | 50 | 47 | 3 | M5583 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.10e-04 | 50 | 47 | 3 | MM14796 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 7.03e-04 | 12 | 47 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 7.03e-04 | 12 | 47 | 2 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 7.03e-04 | 12 | 47 | 2 | MM15452 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 7.24e-04 | 53 | 47 | 3 | MM14566 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 7.65e-04 | 54 | 47 | 3 | M42568 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.91e-04 | 59 | 47 | 3 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.09e-03 | 61 | 47 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.09e-03 | 61 | 47 | 3 | MM14637 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 1.20e-03 | 63 | 47 | 3 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.20e-03 | 63 | 47 | 3 | M39646 | |
| Pathway | PID_IL4_2PATHWAY | 1.25e-03 | 64 | 47 | 3 | M28 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.25e-03 | 64 | 47 | 3 | M26953 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.27e-03 | 16 | 47 | 2 | M9450 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.29e-03 | 143 | 47 | 4 | M27275 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.37e-03 | 66 | 47 | 3 | MM15875 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.43e-03 | 67 | 47 | 3 | M26999 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.43e-03 | 17 | 47 | 2 | MM1509 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 1.43e-03 | 17 | 47 | 2 | M48030 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.62e-03 | 258 | 47 | 5 | MM14572 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 1.79e-03 | 19 | 47 | 2 | M39370 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.79e-03 | 19 | 47 | 2 | M18933 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 1.79e-03 | 19 | 47 | 2 | M48230 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.79e-03 | 19 | 47 | 2 | MM15512 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.06e-03 | 76 | 47 | 3 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.06e-03 | 76 | 47 | 3 | MM14867 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 2.41e-03 | 22 | 47 | 2 | M42534 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.74e-03 | 84 | 47 | 3 | M7098 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 3.11e-03 | 25 | 47 | 2 | M274 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.33e-03 | 90 | 47 | 3 | M631 | |
| Pubmed | Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. | 2.86e-08 | 4 | 68 | 3 | 10490618 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 12524684 | ||
| Pubmed | Engineered Tissue Folding by Mechanical Compaction of the Mesenchyme. | 7.13e-08 | 5 | 68 | 3 | 29290586 | |
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 16192629 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 28541300 | ||
| Pubmed | BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. | 2.64e-07 | 28 | 68 | 4 | 19224984 | |
| Pubmed | 3.41e-07 | 340 | 68 | 8 | 29478914 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 3.98e-07 | 8 | 68 | 3 | 11867580 | |
| Pubmed | Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations. | 3.98e-07 | 8 | 68 | 3 | 27720643 | |
| Pubmed | Tissue-specific knockout of E-cadherin (Cdh1) in developing mouse gonads causes germ cells loss. | 5.95e-07 | 9 | 68 | 3 | 31100714 | |
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 9878537 | ||
| Pubmed | Structural basis of branch site recognition by the human spliceosome. | 8.49e-07 | 10 | 68 | 3 | 34822310 | |
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 9415455 | ||
| Pubmed | A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. | 8.49e-07 | 10 | 68 | 3 | 11500380 | |
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 14559231 | ||
| Pubmed | Role of smooth muscle protein SM22α in glomerular epithelial cell injury. | 8.49e-07 | 10 | 68 | 3 | 21289056 | |
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 33074477 | ||
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 9.38e-07 | 38 | 68 | 4 | 29743679 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 31835801 | ||
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 24248941 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 2.02e-06 | 13 | 68 | 3 | 11839810 | |
| Pubmed | 2.02e-06 | 13 | 68 | 3 | 31961823 | ||
| Pubmed | MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis. | 2.56e-06 | 14 | 68 | 3 | 14627958 | |
| Pubmed | 2.56e-06 | 14 | 68 | 3 | 30459452 | ||
| Pubmed | Epithelial β1 integrin is required for lung branching morphogenesis and alveolarization. | 2.56e-06 | 14 | 68 | 3 | 25395457 | |
| Pubmed | 2.88e-06 | 50 | 68 | 4 | 23658023 | ||
| Pubmed | Induction of Immune Surveillance of the Dysmorphogenic Lens. | 3.20e-06 | 15 | 68 | 3 | 29176738 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 3.20e-06 | 15 | 68 | 3 | 9832566 | |
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 38018454 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 3.37e-06 | 52 | 68 | 4 | 30389913 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32335875 | ||
| Pubmed | Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta. | 3.77e-06 | 2 | 68 | 2 | 36951356 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17211858 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 5529814 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9443882 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15241796 | ||
| Pubmed | Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. | 3.77e-06 | 2 | 68 | 2 | 24668929 | |
| Pubmed | [Relationship of collagen type I alpha 1 and alpha 2 gene polymorphisms with bone mineral density]. | 3.77e-06 | 2 | 68 | 2 | 16864092 | |
| Pubmed | Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. | 3.77e-06 | 2 | 68 | 2 | 1303238 | |
| Pubmed | Regional chromosome mapping of human collagen genes alpha 2(I) and alpha 1(I) (COLIA2 and COLIA1). | 3.77e-06 | 2 | 68 | 2 | 3857213 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 1874719 | ||
| Pubmed | Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis. | 3.77e-06 | 2 | 68 | 2 | 18644377 | |
| Pubmed | COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. | 3.77e-06 | 2 | 68 | 2 | 21344539 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31876392 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23692737 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32091183 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11668615 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 35172811 | ||
| Pubmed | Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants. | 3.77e-06 | 2 | 68 | 2 | 20721936 | |
| Pubmed | A cysteine-based molecular code informs collagen C-propeptide assembly. | 3.77e-06 | 2 | 68 | 2 | 30310058 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10608859 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21405976 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9016532 | ||
| Pubmed | Mutations in type I collagen genes in Japanese osteogenesis imperfecta patients. | 3.77e-06 | 2 | 68 | 2 | 17875077 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19714363 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16188468 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20827171 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21602843 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34727246 | ||
| Pubmed | Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer. | 3.77e-06 | 2 | 68 | 2 | 27894325 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26927310 | ||
| Pubmed | Effects of GABA on the expression of type I collagen gene in normal human dermal fibroblasts. | 3.77e-06 | 2 | 68 | 2 | 27691923 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 36853784 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32166892 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 35909573 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27519266 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.77e-06 | 2 | 68 | 2 | 36717248 | |
| Pubmed | Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). | 3.77e-06 | 2 | 68 | 2 | 10751421 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21193410 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27090748 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 6857446 | ||
| Pubmed | Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta. | 3.77e-06 | 2 | 68 | 2 | 16705691 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10627137 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22325288 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27748872 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7629088 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7881420 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11358497 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11143996 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15211650 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 35915937 | ||
| Pubmed | [Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]. | 3.77e-06 | 2 | 68 | 2 | 37368383 | |
| Pubmed | Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. | 3.77e-06 | 2 | 68 | 2 | 7520724 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8723681 | ||
| Pubmed | Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta. | 3.77e-06 | 2 | 68 | 2 | 36140746 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7945553 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15847701 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20087402 | ||
| Pubmed | Early type I collagen deposition is associated with prognosis in biliary atresia. | 3.77e-06 | 2 | 68 | 2 | 26452701 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8097422 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34902613 | ||
| Pubmed | Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects. | 3.77e-06 | 2 | 68 | 2 | 35044492 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19469869 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28498836 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28981938 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23430339 | ||
| Pubmed | Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients. | 3.77e-06 | 2 | 68 | 2 | 28810924 | |
| Pubmed | Structural basis of homo- and heterotrimerization of collagen I. | 3.77e-06 | 2 | 68 | 2 | 28281531 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23817620 | ||
| Interaction | MIR138-1 interactions | 3.09e-06 | 68 | 67 | 5 | int:MIR138-1 | |
| Interaction | MIR122 interactions | 3.83e-06 | 71 | 67 | 5 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 3.83e-06 | 71 | 67 | 5 | int:MIR29B2 | |
| Interaction | MIR18A interactions | 4.40e-06 | 73 | 67 | 5 | int:MIR18A | |
| Interaction | MIR20A interactions | 4.71e-06 | 74 | 67 | 5 | int:MIR20A | |
| Interaction | MIR15A interactions | 5.03e-06 | 75 | 67 | 5 | int:MIR15A | |
| Interaction | MIR7-3 interactions | 5.37e-06 | 76 | 67 | 5 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 5.37e-06 | 76 | 67 | 5 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 5.37e-06 | 76 | 67 | 5 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 5.37e-06 | 76 | 67 | 5 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 5.73e-06 | 77 | 67 | 5 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 5.73e-06 | 77 | 67 | 5 | int:MIR200A | |
| Interaction | MIR92A1 interactions | 6.11e-06 | 78 | 67 | 5 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 6.11e-06 | 78 | 67 | 5 | int:MIR98 | |
| Interaction | MIR451A interactions | 6.11e-06 | 78 | 67 | 5 | int:MIR451A | |
| Interaction | MIR222 interactions | 6.50e-06 | 79 | 67 | 5 | int:MIR222 | |
| Interaction | MIR206 interactions | 6.50e-06 | 79 | 67 | 5 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 6.50e-06 | 79 | 67 | 5 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 6.50e-06 | 79 | 67 | 5 | int:MIR34C | |
| Interaction | MIR143 interactions | 6.92e-06 | 80 | 67 | 5 | int:MIR143 | |
| Interaction | MIR145 interactions | 7.35e-06 | 81 | 67 | 5 | int:MIR145 | |
| Interaction | MIR10B interactions | 7.81e-06 | 82 | 67 | 5 | int:MIR10B | |
| Interaction | MIR106A interactions | 8.29e-06 | 83 | 67 | 5 | int:MIR106A | |
| Interaction | MIR31 interactions | 8.79e-06 | 84 | 67 | 5 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 8.79e-06 | 84 | 67 | 5 | int:MIR7-2 | |
| Interaction | MIR199A1 interactions | 8.79e-06 | 84 | 67 | 5 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 8.79e-06 | 84 | 67 | 5 | int:MIR200B | |
| Interaction | MIR107 interactions | 9.32e-06 | 85 | 67 | 5 | int:MIR107 | |
| Interaction | MIR17 interactions | 9.32e-06 | 85 | 67 | 5 | int:MIR17 | |
| Interaction | MIR18B interactions | 9.32e-06 | 85 | 67 | 5 | int:MIR18B | |
| Interaction | MIR93 interactions | 9.32e-06 | 85 | 67 | 5 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 9.32e-06 | 85 | 67 | 5 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 9.32e-06 | 85 | 67 | 5 | int:MIR16-2 | |
| Interaction | MIR20B interactions | 9.87e-06 | 86 | 67 | 5 | int:MIR20B | |
| Interaction | MIR29A interactions | 1.04e-05 | 87 | 67 | 5 | int:MIR29A | |
| Interaction | MIR141 interactions | 1.10e-05 | 88 | 67 | 5 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 1.10e-05 | 88 | 67 | 5 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 1.17e-05 | 89 | 67 | 5 | int:MIR29C | |
| Interaction | FANCC interactions | 1.17e-05 | 89 | 67 | 5 | int:FANCC | |
| Interaction | MIR221 interactions | 1.23e-05 | 90 | 67 | 5 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 1.23e-05 | 90 | 67 | 5 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 1.23e-05 | 90 | 67 | 5 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 1.30e-05 | 91 | 67 | 5 | int:MIR200C | |
| Interaction | MIR155 interactions | 1.37e-05 | 92 | 67 | 5 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 1.37e-05 | 92 | 67 | 5 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 1.45e-05 | 93 | 67 | 5 | int:MIR214 | |
| Interaction | MIR205 interactions | 1.45e-05 | 93 | 67 | 5 | int:MIR205 | |
| Interaction | CD93 interactions | 1.50e-05 | 45 | 67 | 4 | int:CD93 | |
| Interaction | MIR19B2 interactions | 1.52e-05 | 94 | 67 | 5 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 1.52e-05 | 94 | 67 | 5 | int:MIRLET7F1 | |
| Interaction | MIRLET7A2 interactions | 1.69e-05 | 96 | 67 | 5 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 1.78e-05 | 97 | 67 | 5 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 1.78e-05 | 97 | 67 | 5 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 1.78e-05 | 97 | 67 | 5 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 1.78e-05 | 97 | 67 | 5 | int:MIR363 | |
| Interaction | MIR106B interactions | 1.87e-05 | 98 | 67 | 5 | int:MIR106B | |
| Interaction | FOXO1 interactions | 1.92e-05 | 347 | 67 | 8 | int:FOXO1 | |
| Interaction | MIR128-2 interactions | 1.96e-05 | 99 | 67 | 5 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 2.06e-05 | 100 | 67 | 5 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 2.16e-05 | 101 | 67 | 5 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 2.16e-05 | 101 | 67 | 5 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 2.16e-05 | 101 | 67 | 5 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 2.27e-05 | 102 | 67 | 5 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 2.38e-05 | 103 | 67 | 5 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 2.38e-05 | 103 | 67 | 5 | int:MIR7-1 | |
| Interaction | MIR19B1 interactions | 2.49e-05 | 104 | 67 | 5 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 2.49e-05 | 104 | 67 | 5 | int:MIR34A | |
| Interaction | MIRLET7E interactions | 2.73e-05 | 106 | 67 | 5 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 2.99e-05 | 108 | 67 | 5 | int:MIRLET7A1 | |
| Interaction | MIR34B interactions | 3.26e-05 | 110 | 67 | 5 | int:MIR34B | |
| Interaction | MIRLET7I interactions | 3.87e-05 | 114 | 67 | 5 | int:MIRLET7I | |
| Interaction | EEF1A1 interactions | NEU1 HDAC4 RTCB AHNAK CARS1 ANKRD24 C8A CDH1 SF3B2 SMAD4 STAT6 | 3.91e-05 | 762 | 67 | 11 | int:EEF1A1 |
| Interaction | SMNDC1 interactions | 4.21e-05 | 116 | 67 | 5 | int:SMNDC1 | |
| Interaction | MIRLET7G interactions | 4.39e-05 | 117 | 67 | 5 | int:MIRLET7G | |
| Interaction | DCPS interactions | 4.74e-05 | 394 | 67 | 8 | int:DCPS | |
| Interaction | SMAD7 interactions | 6.49e-05 | 127 | 67 | 5 | int:SMAD7 | |
| Interaction | TGFBI interactions | 7.67e-05 | 25 | 67 | 3 | int:TGFBI | |
| Interaction | MIR9-3 interactions | 8.67e-05 | 70 | 67 | 4 | int:MIR9-3 | |
| Interaction | MIR140 interactions | 9.17e-05 | 71 | 67 | 4 | int:MIR140 | |
| Interaction | MIR29B1 interactions | 1.02e-04 | 73 | 67 | 4 | int:MIR29B1 | |
| Interaction | RNU11 interactions | 1.08e-04 | 28 | 67 | 3 | int:RNU11 | |
| Interaction | RNU12 interactions | 1.08e-04 | 28 | 67 | 3 | int:RNU12 | |
| Interaction | BGN interactions | 1.34e-04 | 30 | 67 | 3 | int:BGN | |
| Interaction | LUM interactions | 1.63e-04 | 32 | 67 | 3 | int:LUM | |
| Interaction | MMP2 interactions | 2.02e-04 | 87 | 67 | 4 | int:MMP2 | |
| Interaction | FERMT1 interactions | 2.13e-04 | 35 | 67 | 3 | int:FERMT1 | |
| Interaction | WASHC5 interactions | 2.30e-04 | 90 | 67 | 4 | int:WASHC5 | |
| Interaction | WASHC1 interactions | 2.72e-04 | 94 | 67 | 4 | int:WASHC1 | |
| Interaction | USP10 interactions | 4.03e-04 | 290 | 67 | 6 | int:USP10 | |
| Interaction | CDK9 interactions | 4.22e-04 | 685 | 67 | 9 | int:CDK9 | |
| Interaction | CUL7 interactions | ATP6V1A SF3B3 SF3B1 HDAC4 RTCB AHNAK PDCD11 LMNB2 IDH3B SF3B2 | 4.52e-04 | 845 | 67 | 10 | int:CUL7 |
| Interaction | FN1 interactions | COL4A2 SF3B1 ADAMTS4 RTCB AHNAK COPE SMAD4 FERMT3 COL1A1 COL1A2 | 4.65e-04 | 848 | 67 | 10 | int:FN1 |
| Interaction | RNPC3 interactions | 5.46e-04 | 48 | 67 | 3 | int:RNPC3 | |
| Interaction | CYLD interactions | 5.57e-04 | 868 | 67 | 10 | int:CYLD | |
| Interaction | HDAC5 interactions | 5.69e-04 | 432 | 67 | 7 | int:HDAC5 | |
| Interaction | DDX39B interactions | 5.86e-04 | 570 | 67 | 8 | int:DDX39B | |
| Interaction | TTC33 interactions | 6.16e-04 | 50 | 67 | 3 | int:TTC33 | |
| Interaction | SCARNA22 interactions | 6.44e-04 | 118 | 67 | 4 | int:SCARNA22 | |
| Interaction | ARL14 interactions | 6.65e-04 | 119 | 67 | 4 | int:ARL14 | |
| Interaction | RCHY1 interactions | 7.33e-04 | 325 | 67 | 6 | int:RCHY1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.79e-04 | 797 | 68 | 7 | chr19p13 | |
| Cytoband | 6p21.3 | 5.32e-04 | 250 | 68 | 4 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 9.15e-04 | 503 | 68 | 5 | chr6p21 | |
| GeneFamily | WASH complex | 8.63e-05 | 6 | 44 | 2 | 1331 | |
| GeneFamily | Collagens | 1.90e-04 | 46 | 44 | 3 | 490 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 9.64e-04 | 19 | 44 | 2 | 50 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.22e-03 | 134 | 44 | 3 | 861 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.49e-03 | 718 | 44 | 6 | 28 | |
| GeneFamily | Immunoglobulin like domain containing | 1.15e-02 | 193 | 44 | 3 | 594 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 6.23e-06 | 46 | 68 | 4 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 6.79e-06 | 47 | 68 | 4 | M1399 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 2.74e-05 | 610 | 68 | 9 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 2.92e-05 | 615 | 68 | 9 | M8673 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 4.49e-05 | 650 | 68 | 9 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 4.99e-05 | 659 | 68 | 9 | MM1040 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 2.07e-06 | 66 | 67 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 7.10e-05 | 70 | 67 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 7.92e-05 | 72 | 67 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 8.82e-05 | 74 | 67 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 8.82e-05 | 74 | 67 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - vagina | 9.79e-05 | 76 | 67 | 4 | BM Top 100 - vagina | |
| CoexpressionAtlas | BM Top 100 - vulva | 1.32e-04 | 82 | 67 | 4 | BM Top 100 - vulva | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-07 | 186 | 68 | 6 | 246503fd4e6ae24041c606b069eb5fb313e60f73 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-07 | 186 | 68 | 6 | ef93ac469eb4f63db036f14b442c1503b8c6de38 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.34e-07 | 188 | 68 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 194 | 68 | 6 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-07 | 194 | 68 | 6 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.37e-07 | 195 | 68 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.39e-06 | 176 | 68 | 5 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.93e-06 | 183 | 68 | 5 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.41e-06 | 185 | 68 | 5 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.66e-06 | 186 | 68 | 5 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 195 | 68 | 5 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-05 | 196 | 68 | 5 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 68 | 5 | 4d63a274828ebb951db78421c2823453d862cd49 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 197 | 68 | 5 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 68 | 5 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.34e-05 | 199 | 68 | 5 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.34e-05 | 199 | 68 | 5 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|lymphoid / Lineage, cell class and subclass | 1.55e-05 | 98 | 68 | 4 | 4da11182885d5f2673e85bd9c5717939b0268427 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 5.28e-05 | 134 | 68 | 4 | d4b175257c47916ed90cdb5c555c2b26530ce8d5 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.27e-05 | 140 | 68 | 4 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 156 | 68 | 4 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 156 | 68 | 4 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 159 | 68 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 167 | 68 | 4 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 167 | 68 | 4 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 167 | 68 | 4 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.45e-04 | 174 | 68 | 4 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.45e-04 | 174 | 68 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 1.52e-04 | 176 | 68 | 4 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.55e-04 | 177 | 68 | 4 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.58e-04 | 178 | 68 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 178 | 68 | 4 | 1802ff1c6cb18ee62cfef7270c0971048fae5315 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 178 | 68 | 4 | 4368d20130e5a08716564c19470b6014f16902ac | |
| ToppCell | Pericytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-04 | 178 | 68 | 4 | a2448d868da2abe48c394c51264aad03e866dfec | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 178 | 68 | 4 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 178 | 68 | 4 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 178 | 68 | 4 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-04 | 179 | 68 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 180 | 68 | 4 | 1ade66352570a3f869e21e1055d0a65fbf56c61d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 180 | 68 | 4 | f118c580134bdf3027e2218690cfc8a93468c1ae | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 180 | 68 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-04 | 181 | 68 | 4 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-04 | 182 | 68 | 4 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.72e-04 | 182 | 68 | 4 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | c1e0be27064e14043b78ae501b02d4e9542267a3 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-04 | 182 | 68 | 4 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | 3c9b4869d357884ae4bcd22a9872faf83a5cfc6d | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.76e-04 | 183 | 68 | 4 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 184 | 68 | 4 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 184 | 68 | 4 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 184 | 68 | 4 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.80e-04 | 184 | 68 | 4 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 1.80e-04 | 184 | 68 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-04 | 185 | 68 | 4 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.83e-04 | 185 | 68 | 4 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 185 | 68 | 4 | 3dcafbd02b65a2befbb6e6288cb2591e721cddb6 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.87e-04 | 186 | 68 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-04 | 186 | 68 | 4 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-04 | 186 | 68 | 4 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 187 | 68 | 4 | 908df5520142d65fe32a003d26be14965082a1ea | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 187 | 68 | 4 | c1dfab0b0d7f519b9f13f4e0365ab41c4b2ae1ec | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-04 | 187 | 68 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | facs-Skin-Anagen-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 187 | 68 | 4 | b486cc5ac678051fea9d4c7db53b26a5a8427e60 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 68 | 4 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 68 | 4 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 188 | 68 | 4 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 68 | 4 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-04 | 188 | 68 | 4 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-04 | 189 | 68 | 4 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.99e-04 | 189 | 68 | 4 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.99e-04 | 189 | 68 | 4 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.99e-04 | 189 | 68 | 4 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 2.03e-04 | 190 | 68 | 4 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.03e-04 | 190 | 68 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 190 | 68 | 4 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-04 | 190 | 68 | 4 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | droplet-Limb_Muscle|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 190 | 68 | 4 | 06c2b13fa88abbcb8086f13b8d98a156e41e4198 | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 190 | 68 | 4 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-04 | 190 | 68 | 4 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 2.07e-04 | 191 | 68 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-04 | 191 | 68 | 4 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 191 | 68 | 4 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 191 | 68 | 4 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-04 | 191 | 68 | 4 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.07e-04 | 191 | 68 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-04 | 191 | 68 | 4 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-04 | 192 | 68 | 4 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 192 | 68 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-04 | 192 | 68 | 4 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | Hippocampus-Endothelial|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.11e-04 | 192 | 68 | 4 | 36deadab892d3e639a71f33697bb2d3cbbaa5372 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 192 | 68 | 4 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 192 | 68 | 4 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 193 | 68 | 4 | 54506c0da2f219f472b95e8935a78b657a8dec41 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-04 | 193 | 68 | 4 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-04 | 193 | 68 | 4 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 193 | 68 | 4 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| Drug | malate | 3.69e-06 | 219 | 67 | 7 | CID000000525 | |
| Drug | 5'-methylthioadenosine | 8.53e-06 | 2 | 67 | 2 | ctd:C008500 | |
| Drug | ascorbate-2-phosphate | 1.08e-05 | 15 | 67 | 3 | ctd:C011669 | |
| Drug | glyphosate | 1.09e-05 | 479 | 67 | 9 | ctd:C010974 | |
| Drug | maltos | 1.97e-05 | 393 | 67 | 8 | CID000000294 | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 4585_UP | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 67 | 6 | 3164_UP | |
| Drug | 4-oxoretinol | 4.14e-05 | 23 | 67 | 3 | ctd:C041819 | |
| Drug | glycolic acid | 4.30e-05 | 66 | 67 | 4 | CID000000757 | |
| Drug | Collagenase | 5.10e-05 | 4 | 67 | 2 | DB00048 | |
| Drug | diacetylrhein | 5.10e-05 | 4 | 67 | 2 | ctd:C025292 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 8.70e-08 | 50 | 65 | 5 | DOID:3770 (biomarker_via_orthology) | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 1.02e-07 | 5 | 65 | 3 | DOID:12347 (implicated_via_orthology) | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 4.78e-06 | 2 | 65 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 4.78e-06 | 2 | 65 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 4.78e-06 | 2 | 65 | 2 | C4551623 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 4.78e-06 | 2 | 65 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 4.78e-06 | 2 | 65 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 4.78e-06 | 2 | 65 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 4.78e-06 | 2 | 65 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 4.78e-06 | 2 | 65 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 4.78e-06 | 2 | 65 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 4.78e-06 | 2 | 65 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 4.78e-06 | 2 | 65 | 2 | 259420 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.79e-06 | 53 | 65 | 4 | C4707243 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 1.43e-05 | 3 | 65 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | OSTEOPOROSIS | 2.86e-05 | 4 | 65 | 2 | 166710 | |
| Disease | Brachydactyly | 2.86e-05 | 4 | 65 | 2 | C0221357 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 4.76e-05 | 5 | 65 | 2 | C0268358 | |
| Disease | Lobstein Disease | 4.76e-05 | 5 | 65 | 2 | C0023931 | |
| Disease | Ehlers-Danlos Syndrome | 4.76e-05 | 5 | 65 | 2 | C0013720 | |
| Disease | Osteoporosis | 7.13e-05 | 6 | 65 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 7.13e-05 | 6 | 65 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Bleeding tendency | 9.96e-05 | 7 | 65 | 2 | C1458140 | |
| Disease | peak expiratory flow | 1.12e-04 | 498 | 65 | 7 | EFO_0009718 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 2.13e-04 | 10 | 65 | 2 | C0268363 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 2.59e-04 | 11 | 65 | 2 | C0268362 | |
| Disease | Mammary Ductal Carcinoma | 2.59e-04 | 11 | 65 | 2 | C0021367 | |
| Disease | Invasive Ductal Breast Carcinoma | 2.59e-04 | 11 | 65 | 2 | C1134719 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 2.59e-04 | 11 | 65 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 3.67e-04 | 13 | 65 | 2 | C0029434 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 4.36e-04 | 160 | 65 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | rheumatoid arthritis (is_marker_for) | 4.82e-04 | 69 | 65 | 3 | DOID:7148 (is_marker_for) | |
| Disease | Blood Coagulation Disorders | 5.62e-04 | 16 | 65 | 2 | C0005779 | |
| Disease | Idiopathic pulmonary arterial hypertension | 5.62e-04 | 16 | 65 | 2 | C3203102 | |
| Disease | Familial primary pulmonary hypertension | 6.36e-04 | 17 | 65 | 2 | C0340543 | |
| Disease | Antihistamine use measurement | 6.36e-04 | 17 | 65 | 2 | EFO_0009943 | |
| Disease | renal fibrosis (implicated_via_orthology) | 6.36e-04 | 17 | 65 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Familial Progressive Myoclonic Epilepsy | 6.36e-04 | 17 | 65 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 6.36e-04 | 17 | 65 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 6.36e-04 | 17 | 65 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 6.36e-04 | 17 | 65 | 2 | C0751780 | |
| Disease | May-White Syndrome | 6.36e-04 | 17 | 65 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 6.36e-04 | 17 | 65 | 2 | C0751781 | |
| Disease | Oral Submucous Fibrosis | 7.15e-04 | 18 | 65 | 2 | C0029172 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 7.15e-04 | 18 | 65 | 2 | C0751779 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 7.43e-04 | 80 | 65 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Hydrops Fetalis | 7.98e-04 | 19 | 65 | 2 | C0020305 | |
| Disease | osteoarthritis (biomarker_via_orthology) | 9.77e-04 | 21 | 65 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | Osteogenesis imperfecta | 9.77e-04 | 21 | 65 | 2 | cv:C0029434 | |
| Disease | Heart valve disease | 1.50e-03 | 26 | 65 | 2 | C0018824 | |
| Disease | Liver Cirrhosis | 1.54e-03 | 103 | 65 | 3 | C0023890 | |
| Disease | Liver Cirrhosis, Experimental | 1.55e-03 | 774 | 65 | 7 | C0023893 | |
| Disease | Nephrotic Syndrome | 1.62e-03 | 27 | 65 | 2 | C0027726 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.63e-03 | 105 | 65 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | Fibrosis, Liver | 1.63e-03 | 105 | 65 | 3 | C0239946 | |
| Disease | Carcinoma, Ovarian Epithelial | 2.00e-03 | 30 | 65 | 2 | C4721610 | |
| Disease | osteoporosis (is_implicated_in) | 2.13e-03 | 31 | 65 | 2 | DOID:11476 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSFGVTIGIGPAGSP | 246 | P07357 | |
| TEGDIGFPGITGVTG | 1126 | P08572 | |
| GPSTPTGTLEFEGGE | 5791 | Q09666 | |
| PGPASGGSGEVDELF | 6 | O14579 | |
| GVGAGQAEPPVTGTT | 656 | Q8TF21 | |
| ETIEGVFSPASPGAG | 706 | Q9H324 | |
| VVEPEGGAVAPGGTV | 241 | Q15109 | |
| IEPGEEGPTAGSVGG | 321 | Q15109 | |
| ESPEGVPIEGIIFGG | 421 | P35558 | |
| VDSITAAGGEGPFPT | 1521 | Q9Y4B5 | |
| GSTGGVTGGFIPVPD | 646 | P32926 | |
| VTGGFIPVPDGSEGT | 651 | P32926 | |
| APDEVGTGPGVGFNV | 876 | P56524 | |
| LFAVSVEFGPGPGTG | 871 | Q9H8L6 | |
| VEEPLGSGPSVLGTG | 441 | Q03252 | |
| GEVTGFGEPLSPGEI | 596 | Q5HYC2 | |
| PSGPVTAEDQGGILG | 271 | Q9Y2U2 | |
| AGTPSEGSFLPGAVV | 126 | Q5VZ46 | |
| AEGSGTTGPPIVGET | 2931 | Q7Z5P9 | |
| AGVTGITGPFAEVTG | 6026 | Q7Z5P9 | |
| RTEAPGGTSGEFPGT | 6546 | Q7Z5P9 | |
| EAPGGTSGEFPGTRI | 6656 | Q7Z5P9 | |
| GTSGGYVPGRETEPT | 7531 | Q7Z5P9 | |
| VGVASVGVGPEPLQG | 136 | A6NDG6 | |
| PGTGLPTVGLFSFGD | 186 | Q96RT7 | |
| NPTGVVLVSGEPGSG | 61 | Q8TE96 | |
| GISAVPSPGEEEGGT | 676 | P16112 | |
| GSPDVSGEIPGLFGV | 1721 | P16112 | |
| SGEIPGLFGVSGQPS | 1726 | P16112 | |
| TGEVGAVGPPGFAGE | 831 | P08123 | |
| ILGSGEEGPQVGPSA | 271 | O75173 | |
| EGSFPVTMLPGDGVG | 46 | O43837 | |
| PGTVGTGLGGTAEDP | 241 | Q13351 | |
| ETVAGPGEGTVAPTA | 56 | P14138 | |
| VSQEDVELPPGGFGG | 126 | P0C2L3 | |
| PGTSRGPDVGVGESQ | 26 | Q6MZW2 | |
| PIIPFGTGTGLEGGV | 91 | Q86WU2 | |
| GGTLLGPPDSVVDVG | 61 | Q6ICB0 | |
| GGGGTDTTPVRPVKF | 601 | Q68DC2 | |
| FGGTSPSPEEGLGDE | 306 | Q9BQ90 | |
| GAVAVTDGGPFRPEG | 4436 | P21817 | |
| SITGQGADTPPVGVF | 191 | P12830 | |
| VEEITGTQPPYGGGT | 871 | Q8N4C8 | |
| DPEAVVSPGGVGFDI | 106 | Q9Y3I0 | |
| AEDTSLGPGVPGTGE | 91 | Q6ZW31 | |
| VEEDSSLGFPVGGPG | 561 | P49589 | |
| PIVTVDGYVDPSGGD | 346 | Q13485 | |
| IGTEVFAPGPGSGIQ | 191 | Q99519 | |
| DVGSFLGPGVPAAGV | 316 | O95081 | |
| ESGDIGPGSGAVEAP | 111 | Q8N6U2 | |
| GYDEKSTGGISVPGP | 166 | P02452 | |
| VLEDGSVVFSGGPVP | 856 | Q14690 | |
| VPGDGVEFPSSTGAE | 686 | Q92618 | |
| GFITPADSGLITPGG | 736 | Q13435 | |
| AGSGVPGSGLGEEVP | 341 | Q96CK0 | |
| SIAGGVGSPLGDVPI | 1876 | O75970 | |
| FSGGPGITFGVAPST | 751 | Q12816 | |
| PTEEPFSSGGGGSVQ | 76 | Q96AG3 | |
| TDRGGDSIGETPTPG | 316 | O75533 | |
| VPQGPGAGAESTGEI | 326 | P42226 | |
| FSGLVVTEGEPPSGG | 711 | Q6IQ55 | |
| IISGGEEPPVVASGG | 851 | Q9P1Z0 | |
| EGSVSIVGAVSPPGG | 401 | P38606 | |
| VPVLPGSGEAGVSFD | 981 | Q9Y4E1 | |
| QSGEVGEPAGTDPGL | 306 | Q86UX7 | |
| GPPGTEIEITGSNFG | 1926 | Q86WI1 | |
| GSGPFSEIVLSAPEG | 591 | Q9P2J2 | |
| ITVPGGSDGPSGVLI | 236 | Q15393 | |
| AGTAGGTVPATIGPA | 171 | Q9UFB7 | |
| GVPPLGVSGGESFES | 511 | Q9H869 | |
| SEQTPGGPSFVFTGI | 111 | Q8WUU8 | |
| GGPGTEPVTVAAAAV | 1461 | A7E2V4 | |
| SVPVLPGSGEAGVSF | 1001 | Q641Q2 | |
| GSGPDTRTPGTVEDG | 26 | Q9ULZ0 | |
| LSLEDGGPGPESSGV | 16 | Q9H6X4 | |
| TPYVETLEPGGSGGS | 531 | Q96QC0 | |
| VFPAPVVGSGGATSG | 241 | O15209 |